Cargando…
The inhibitory effect of oridonin on colon cancer was mediated by deactivation of TGF-β1/Smads-PAI-1 signaling pathway in vitro and vivo
BACKGROUND: Oridonin, the main active component of Rabdosia rubescens, has been demonstrated to have anti-tumor effect on all kinds of cancer cells through various mechanisms and it has shown antitumor activity in some tumors partially via the suppression of TGF-β/Smads signaling pathway. The aim of...
Autores principales: | Bu, He-Qi, Shen, Feng, Cui, Junhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752205/ https://www.ncbi.nlm.nih.gov/pubmed/31686852 http://dx.doi.org/10.2147/OTT.S220401 |
Ejemplares similares
-
Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells
por: Bu, Heqi, et al.
Publicado: (2019) -
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
por: Kawarada, Yuki, et al.
Publicado: (2016) -
Oridonin Inhibits Myofibroblast Differentiation and Bleomycin-induced Pulmonary Fibrosis by Regulating Transforming Growth Factor β (TGFβ)/Smad Pathway
por: Fu, Yu, et al.
Publicado: (2018) -
Loureirin B Alleviates Myocardial Ischemia/Reperfusion Injury via Inhibiting PAI-1/TGF-β1/Smad Signaling Pathway
por: Kong, Fei, et al.
Publicado: (2022) -
Redox-Induced Src Kinase and Caveolin-1 Signaling in TGF-β1-Initiated SMAD2/3 Activation and PAI-1 Expression
por: Samarakoon, Rohan, et al.
Publicado: (2011)